If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Get Updates
320
Followers on Owler
AbCellera
is a Canada-based biotechnology company that researches and develops antibody therapeutics for the treatment of viral infections...
Read more
Overview
Competitors
Acquisitions
Funding
Investments
News & Insights
AbCellera
is a Canada-based biotechnology company that researches and develops antibody therapeutics for the treatment of viral infections...
Read more
CEO
Carl Hansen
CEO Approval Rating
90/100
Weigh In
2012
Vancouver
British Columbia
Public
NASDAQ
ABCL
Pharmaceuticals & Biotechnology
Biotechnology
8000
NAICS listing
https://abcellera.com/
Annual Revenue
$28.8M
Employees
596
Funding
$1.4B
Acquisitions
4
Investments
1
News
Key Events
Latest News
Partnership
Jan 13, 2025
Yahoo
AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology
Conference Presentation
Nov 21, 2024
Benzinga
AbCellera to Present at Upcoming Investor Conferences in December and January
Follow and Get Alerts
AbCellera Competitors
1
Follow
2
Follow
3
Follow
4
Follow
5
Follow
6
Follow
7
Follow
8
Follow
9
Follow
10
Follow
Unlock 14 + competitors
Trending Companies
